vTv Therapeutics Inc. (VTVT) has a negative trailing P/E of -11.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -8.52%.
Criteria proven by this page:
Overall SharesGrow Score: 45/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -2.8 | 0.06 | -0.51 | 72.72 | - |
| 2017 | -3.6 | 1.30 | -0.39 | 200.19 | - |
| 2018 | -4.2 | 0.07 | -0.40 | 2.65 | - |
| 2019 | -2.3 | -0.17 | -1.05 | 18.63 | - |
| 2020 | -10.3 | 0.14 | -1.09 | 13.67 | - |
| 2021 | -4.8 | -0.32 | -6.40 | 15.56 | - |
| 2022 | -2.7 | -0.13 | -4.74 | 25.23 | - |
| 2023 | -1.2 | 0.44 | -0.97 | 0.00 | - |
| 2024 | -4.3 | 0.06 | 6.53 | 78.37 | - |
| 2025 | -12.5 | 0.00 | 5.23 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-68.52 | $634K | $-16.35M | -2579.2% |
| 2017 | $-66.62 | $291K | $-16.14M | -5547.8% |
| 2018 | $-25.42 | $12.43M | $-7.91M | -63.6% |
| 2019 | $-28.97 | $2.76M | $-21.94M | -793.7% |
| 2020 | $-7.49 | $6.41M | $-8.83M | -137.6% |
| 2021 | $-11.32 | $4.01M | $-17.73M | -442.7% |
| 2022 | $-13.06 | $2.02M | $-25.07M | -1242.5% |
| 2023 | $-9.71 | $0.00 | $-20.25M | - |
| 2024 | $-3.20 | $1.02M | $-18.46M | -1815.3% |
| 2025 | $-3.20 | $0.00 | $-26.97M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-2.57 | $-4.62 – $-0.99 | $13.33M | $13.33M – $13.33M | 4 |
| 2027 | $-3.72 | $-5.58 – $-2.73 | $800K | $800K – $800K | 4 |
| 2028 | $-3.94 | $-7.06 – $-2.56 | $5.8M | $5.8M – $5.8M | 5 |
| 2029 | $-4.14 | $-4.14 – $-4.14 | $8.23M | $8.23M – $8.23M | 1 |
| 2030 | $-1.49 | $-1.49 – $-1.49 | $57.94M | $57.94M – $57.94M | 1 |
